Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000905718-16-001599
Filing Date
2016-08-12
Accepted
2016-08-12 16:31:16
Documents
1
Effectiveness Date
2016-08-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13181
  Complete submission text file 0000905718-16-001599.txt   14330
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-268870 | Film No.: 161828642
SIC: 2834 Pharmaceutical Preparations